|Stem cell therapy drug may protect against smoke-related COPD symptoms|
Added: 14.11.2018 18:20 | 2 views | 0 comments
A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury.
|Unique stem cells as a potential asthma treatment|
Added: 14.11.2018 18:20 | 1 views | 0 comments
A new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.
|Cancer stem cells get energy from protein, and it's proving to be their Achilles' heel|
Added: 13.11.2018 17:23 | 10 views | 0 comments
A new study shows that cancer stem cells switch from metabolizing sugar to metabolizing protein. Clinical trial based on this observation may revolutionize care for older adults with acute myeloid leukemia.
|Advance stem cell therapy with biodegradable scaffold|
Added: 12.11.2018 21:22 | 9 views | 0 comments
Scientists have created a tiny, biodegradable scaffold to transplant stem cells and deliver drugs, which may help treat Alzheimer's and Parkinson's diseases, aging brain degeneration, spinal cord injuries and traumatic brain injuries. Stem cell transplantation, which shows promise as a treatment for central nervous system diseases, has been hampered by low cell survival rates, incomplete differentiation of cells and limited growth of neural connections.
|Givaudan aims to protect hair from free radical-induced whitening|
Added: 12.11.2018 14:17 | 14 views | 0 comments
Givaudan tackles hair whitening from the inside thanks to a new active ingredient that boost hair stem cells proliferation and protects hair follicles from free radicals. The loss of pigmentation in the hair shaft (hair greying) is one of the most obvious signs of ageing, and one of the main beauty concerns of ageing. Indeed, between 45 and 65 years old, 74% of the worldwide population is affected by greying hair. According to Givaudan Active Beauty, 59% of consumers are worried about hair (...)
|Small populations of normal cells affect immunity in patients with XLP1|
Added: 12.11.2018 2:17 | 7 views | 0 comments
Human SH2D1A mutations resulting in X-linked lymphoproliferative syndrome type 1 (XLP1) are associated with a unique susceptibility to the Epstein-Barr virus (EBV), which may lead to fatal infectious mononucleosis (FIM). Many studies have attempted to elucidate an appropriate treatment for XLP1 that does not involve hematopoietic stem cell transplantation (HSCT); clinical evidence supporting such treatments has been minimal, until now.
|Inflammation trains the skin to heal faster|
Added: 10.11.2018 17:46 | 3 views | 0 comments
Stem cells in the skin remember an injury, helping them close recurring wounds faster, researchers have found. The discovery could advance research and treatment of psoriasis and other inflammatory diseases.
|Twenty years on, measuring the impact of human stem cells|
Added: 09.11.2018 18:50 | 6 views | 0 comments
A new paper describes the global scope and economic impact of stem cell science, including the clinical, industrial and research use of the cells.
|Human placenta stem cells help people recover from hip surgery|
Added: 09.11.2018 18:47 | 2 views | 0 comments
The placenta is usually discarded after childbirth but it's a source of mesenchymal stem cells – and they help people regain muscle strength after hip surgery
|Gene therapy via skin protects mice from lethal cocaine doses|
Added: 09.11.2018 18:40 | 5 views | 0 comments
A new study shows that skin stem cells, modified via CRISPR and transplanted back to donor mice, can protect addicted mice from cocaine-seeking and overdose.